(Q37827023)

23 August 2017

1 reference

title

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. (English)

1 reference

23 August 2017

0 references

chronic heart failure

1 reference

Donato Mele

8

0 references

Claudio Passino

Claudio Passino

9

0 references

Giuseppe Boriani

Giuseppe Boriani

3

0 references

Marco Guazzi

Marco Guazzi

2

0 references

Giovanni Quinto Villani

12

Giovanni Villani

1 reference

23 August 2017

7

Michele Emdin

1 reference

23 August 2017

Mariantonietta Cicoira

4

Mariantonietta Cicoira

1 reference

23 August 2017

5

Ugo Corrà

1 reference

23 August 2017

6

Luciano Dalla Libera

1 reference

23 August 2017

11

Carlo Vigorito

1 reference

23 August 2017

Massimo F Piepoli

1

1 reference

23 August 2017

Giorgio Vescovo

10

1 reference

23 August 2017

Piergiuseppe Agostoni

13

1 reference

23 August 2017

Working Group ‘Exercise Physiology, Sport Cardiology and Cardiac Rehabilitation’, Italian Society of Cardiology

14

1 reference

23 August 2017

publication date

1 December 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

23 August 2017

published in

1 reference

23 August 2017

volume

17

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

643-648

1 reference

Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Carotid chemoreceptor modulation of sympathetic vasoconstrictor outflow during exercise in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Wasting as independent risk factor for mortality in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Reduced Peripheral Skeletal Muscle Mass and Abnormal Reflex Physiology in Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Long-term use of sildenafil in the therapeutic management of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Alveolar epithelial beta 2-adrenergic receptors: their role in regulation of alveolar active sodium transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Effect of exercise on coronary endothelial function in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Resistance exercise: training adaptations and developing a safe exercise prescription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Exercise training in patients with chronic heart failure: Authors' reply.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Cardiac resynchronization by pacing: an electrical treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Effect of biventricular pacing on the exercise pathophysiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833F3AA5

10.1097/HJR.0B013E32833F3AA5

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference